Safety of Plasma Volume Expanders

The Effects of Hydroxyethyl Starch 130/0.4 (6%) on Blood Loss and Use of Blood Products in Major Surgery: A Pooled Analysis of Randomized Clinical Trials

(2009) Sibylle A. Kozek-Langenecker et al.   ANESTHESIA AND ANALGESIA

Hydroxyethyl Starch 130/0.4 and Surgical Blood Loss

(2009) Sibylle A. Kozek-Langenecker et al.   ANESTHESIA AND ANALGESIA

Albumin Usage in Clinical Medicine: Tradition or Therapeutic?

(2009) Albert Farrugia   TRANSFUSION MEDICINE REVIEWS

Rapidly Degradable Hydroxyethyl Starch Solutions Impair Blood Coagulation After Cardiac Surgery: A Prospective Randomized Trial

(2008) Alexey A. Schramko et al.   ANESTHESIA AND ANALGESIA

Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation

(2008) V. Blasco et al.   BRITISH JOURNAL OF ANAESTHESIA

RETRACTED: Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery

(2008) J. Boldt et al.   BRITISH JOURNAL OF ANAESTHESIA

The risk associated with hyperoncotic colloids in patients with shock

(2008) Frédérique Schortgen et al.   INTENSIVE CARE MEDICINE

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis

(2008) Frank M. Brunkhorst et al.   NEW ENGLAND JOURNAL OF MEDICINE